标题
The Alzheimer’s disease drug development landscape
作者
关键词
-
出版物
Alzheimers Research & Therapy
Volume 13, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-11-11
DOI
10.1186/s13195-021-00927-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Alzheimer's disease
- (2021) Philip Scheltens et al. LANCET
- A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
- (2021) Chad J. Swanson et al. Alzheimers Research & Therapy
- The multiplex model of the genetics of Alzheimer’s disease
- (2020) Rebecca Sims et al. NATURE NEUROSCIENCE
- A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
- (2020) Harald Hampel et al. Frontiers in Immunology
- Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease
- (2020) Alette M. Wessels et al. Alzheimers & Dementia
- Immune response and endocytosis pathways are associated with the resilience against Alzheimer’s disease
- (2020) Niccolò Tesi et al. Translational Psychiatry
- Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
- (2019) Iris E. Jansen et al. NATURE GENETICS
- The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules
- (2019) Beatriz G. de la Torre et al. MOLECULES
- Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons
- (2019) Rik van der Kant et al. Cell Stem Cell
- Current and emerging avenues for Alzheimer's disease drug targets
- (2019) R. Loera‐Valencia et al. JOURNAL OF INTERNAL MEDICINE
- The “rights” of precision drug development for Alzheimer’s disease
- (2019) Jeffrey Cummings et al. Alzheimers Research & Therapy
- Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Emma Nichols et al. LANCET NEUROLOGY
- Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States
- (2017) Scott M Lassman et al. BMJ Open
- Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease
- (2016) Rik Ossenkoppele et al. BRAIN
- The Cellular Phase of Alzheimer’s Disease
- (2016) Bart De Strooper et al. CELL
- The impact of low-frequency and rare variants on lipid levels
- (2015) Ida Surakka et al. NATURE GENETICS
- Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology
- (2013) J Chapuis et al. MOLECULAR PSYCHIATRY
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
- (2013) Jean-Charles Lambert et al. NATURE GENETICS
- Common Alzheimer’s Disease Research Ontology: National Institute on Aging and Alzheimer’s Association Collaborative Project
- (2012) Lorenzo M. Refolo et al. Alzheimers & Dementia
- Role of Phosphatidylinositol Clathrin Assembly Lymphoid-Myeloid Leukemia (PICALM) in Intracellular Amyloid Precursor Protein (APP) Processing and Amyloid Plaque Pathogenesis
- (2012) Qingli Xiao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Drug discovery: new models for industry–academic partnerships
- (2008) Cathy J. Tralau-Stewart et al. DRUG DISCOVERY TODAY
- Common and rare variants in multifactorial susceptibility to common diseases
- (2008) Walter Bodmer et al. NATURE GENETICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now